Takeda Pharmaceutical Company (TAK) Income Statement: Revenue & Earnings

Takeda Pharmaceutical Company Income Statement Analysis

Revenue, earnings, and profit margins in trillions JPY

Scale:

Scroll to see more

Takeda Pharmaceutical Company Limited income statement - Annual data in trillions JPY
Breakdown	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Mar 2025	Dec 2024	Mar 2024	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Revenue & Gross Profit
Revenue	4.58	4.58	4.26	4.03	3.57	3.20	3.29	2.10
Cost of Revenue	1.58	1.58	1.43	1.24	1.11	0.99	1.09	0.65
Gross Profit	3.00	3.00	2.84	2.78	2.46	2.20	2.20	1.45
Operating Expenses
Research & Development	0.73	0.73	0.73	0.63	0.53	0.46	0.49	0.37
Selling, General & Administrative	1.10	1.10	1.05	1.00	0.89	0.88	0.96	0.72
Operating Expenses	2.52	2.66	2.54	2.32	2.21	1.87	1.93	1.26
Operating Income	0.49	0.34	0.30	0.30	0.25	0.34	0.27	0.19
Other Income/Expense
Interest Income	0.02	0.02	0.01	0.00	0.00	0.00	0.01	0.01
Interest Expense	0.14	0.14	-0.12	0.12	-0.13	0.13	0.15	0.05
Other Income/Expense	-0.17	-0.17	-0.01	-0.33	-0.03	0.17	-0.19	0.00
Income
Income Before Tax	0.18	0.18	0.05	0.69	0.53	0.37	-0.06	0.13
Income Tax Expense	0.07	0.07	-0.09	0.06	0.07	-0.01	-0.11	-0.01
Net Income	0.11	0.11	0.14	0.32	0.46	0.38	0.04	0.14
Net Income - Continuous Operations	0.11	0.11	0.32	0.23	0.00	0.00	0.00	0.00
Net Income - Discontinued Operations	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
EBITDA	1.07	1.21	0.93	1.16	0.99	1.06	0.67	0.42
EBIT	0.31	0.50	0.21	0.49	0.41	0.50	0.09	0.18
Depreciation & Amortization	0.64	0.76	0.65	0.54	0.47	0.42	0.46	0.18
Earnings Per Share
Basic EPS	34.00	34.00	92.00	204.00	147.00	120.00	14.00	57.00
Diluted EPS	34.00	34.00	91.00	202.00	146.00	119.00	14.00	56.00
Basic Shares Outstanding	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Diluted Shares Outstanding	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00